18 not yet recruiting, 12 completed, 9 recruiting, 1 unknown. 26 Not applicable, 4 Phase 2, 2 Phase 1, 2 Phase 3, 1 Phase 4.
Follow SCHIZOPHRENIA 1 (Disorder): new trials by email Literature Review of SCHIZOPHRENIA 1 (Disorder) trials Research Report on SCHIZOPHRENIA 1 (Disorder)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2 Motion Perception Task, Sine Wave Speech Task, Volatility Task - SCHIZOPHRENIA 1 (Disorder), Schizo Affective Disorder | Not applicable | Not yet recruiting | Washington University School of Medicine | 325 | 2028-04-01 | 2026-11-09 |
| Developing a Virtual Reality-assisted Intervention for Emotion Regulation Difficulties in Psychosis MANOEUVRE therapy - Psychosis, SCHIZOPHRENIA 1 (Disorder) | Not applicable | Not yet recruiting | King's College London | 15 | 2027-09-01 | 2026-06-03 |
| Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual Treatment Bipolar Disorder (BD), SCHIZOPHRENIA 1 (Disorder) | Not yet recruiting | International University of La Rioja | 30 | 2027-02-01 | 2026-11-06 | |
| Brain Imaging of DSP-2342 DSP-2342 - SCHIZOPHRENIA 1 (Disorder) | Phase 2 | Not yet recruiting | Johns Hopkins University | 20 | 2027-01-01 | 2026-09-30 |
| Online Intervention To Improve Motivation Online Motivation Enhancing Intervention - Schizophrenia Prodromal, SCHIZOPHRENIA 1 (Disorder) | Not applicable | Not yet recruiting | University of Alabama at Birmingham | 60 | 2026-12-01 | 2026-10-13 |
| Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 3 Motion Perception Task, Sine Wave Speech Task, Volatility Task - Schizophrenia / Schizoaffective Disorder, SCHIZOPHRENIA 1 (Disorder) | Not applicable | Recruiting | Washington University School of Medicine | 10000 | 2026-12-01 | 2026-11-09 |
| Higher-Dose Maintenance With ERZOFRI 351 mg in Adults With Schizophrenia Paliperidone Palmitate - SCHIZOPHRENIA 1 (Disorder) | Phase 4 | Not yet recruiting | Alejandro Alva | 40 | 2026-12-01 | 2026-11-10 |
| Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1 Motion Perception Task, Sine Wave Speech Task, Volatility Task - SCHIZOPHRENIA 1 (Disorder), Schizoaffective Disorder | Not applicable | Recruiting | Washington University School of Medicine | 325 | 2026-11-15 | 2026-11-09 |
| Confirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophrenia EEG Neurofeedback - SCHIZOPHRENIA 1 (Disorder), Schizoaffecitve Disorder | Phase 2 | Recruiting | University of California, San Diego | 104 | 2026-11-05 | 2026-11-10 |
| Phase 3 Study of HS-10380 for Acute Schizophrenia in Chinese Adults HS-10380, Aripiprazole, Placebo - SCHIZOPHRENIA 1 (Disorder) | Phase 3 | Not yet recruiting | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 476 | 2026-11-04 | 2026-11-03 |
| The Effect of ACT-Based Nursing Interventions on Social Cognition, Emotion Regulation and Psychological Flexibility in Patients With Schizophrenia Acceptance and Commitment Therapy (ACT)-Based Nursing Intervention - SCHIZOPHRENIA 1 (Disorder) | Not applicable | Not yet recruiting | Ataturk University | 64 | 2026-10-01 | 2026-06-22 |
| Multi-target TMS for Schizophrenia Negative Symptoms repetitive transcranial magnetic stimulation (rTMS) - SCHIZOPHRENIA 1 (Disorder) | Not applicable | Not yet recruiting | Shanghai Mental Health Center | 64 | 2026-10-01 | 2026-09-10 |
| Time Course of Clozapine-associated Agranulocytosis Over 19 Years Agranulocytosis, Neutropenia | Completed | Sheba Medical Center | 2020 | 2026-09-10 | 2026-11-03 | |
| A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia HS-10380 - SCHIZOPHRENIA 1 (Disorder) | Phase 3 | Not yet recruiting | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 500 | 2026-09-09 | 2026-08-12 |
| Basal Stimulation Therapy in Adults With Schizophrenia Requiring Institutional Care physiotherapy, 2 x a week for 6 weeks, basal therapy, 2 x a week for 6 weeks, Standard therapy group - SCHIZOPHRENIA 1 (Disorder) | Not applicable | Not yet recruiting | The Jerzy Kukuczka Academy of Physical Education in Katowice | 12 | 2026-09-01 | 2026-08-18 |
| Snoezelen Therapy in Adults With Alcohol Dependence and Adults With Schizophrenia Snoezelen® therapy for 6 weeks, Snoezelen® therapy for 12 weeks - SCHIZOPHRENIA 1 (Disorder), Alcohol Use Disorder | Not applicable | Not yet recruiting | The Jerzy Kukuczka Academy of Physical Education in Katowice | 140 | 2026-09-01 | 2026-08-05 |
| Ultrasound Assessment of Gluteal Muscle in Patients Receiving Depot Antipsychotics and Healthy Volunteers Psychotic Disorder, SCHIZOPHRENIA 1 (Disorder) | Not yet recruiting | St. Olavs Hospital | 60 | 2026-09-01 | 2026-09-11 | |
| Building a Computational Model of Auditory Hallucinations Schizophrenia / Schizoaffective Disorder, Schizophrenia and Disorders With Psychotic Feature | Not yet recruiting | King's College London | 146 | 2026-09-01 | 2026-09-15 | |
| Nurse-Led Simulation-Based Prosocial Skills Training in Individuals With Schizophrenia Nurse-Led Simulation-Based Prosocial Skills Training - SCHIZOPHRENIA 1 (Disorder) | Not applicable | Completed | Selcuk University | 50 | 2026-08-03 | 2026-11-13 |
| ACT-Based Psychoeducation for Caregivers of Patients With Schizophrenia Acceptance and Commitment Therapy (ACT)-Based Psychoeducation Program - SCHIZOPHRENIA 1 (Disorder) | Not applicable | Not yet recruiting | Aydin Adnan Menderes University | 60 | 2026-07-01 | 2026-06-18 |
Showing 20 of 40. Sign in to see all of them.
Schizophrenia (28) · Psychotic Disorders (10) · Emotional Regulation (2) · Schizotypal Personality Disorder (2) · Agranulocytosis (1) · Alcoholism (1) · Anxiety Disorders (1) · Bipolar Disorder (1) · Borderline Personality Disorder (1) · Depressive Disorder, Major (1) · Generalized Anxiety Disorder (1) · Hallucinations (1) · Mental Disorders (1) · Metabolic Syndrome (1) · Neutropenia (1)
Mental Disorders (33) · Schizophrenia Spectrum and Other Psychotic Disorders (32) · Behavior (4) · Nervous System Diseases (3) · Personality Disorders (3) · Chemically-Induced Disorders (2) · Mood Disorders (2) · Self-Control (2) · Sleep Wake Disorders (2) · Social Behavior (2) · Alcohol-Related Disorders (1) · Bipolar and Related Disorders (1) · Cytopenia (1) · Depressive Disorder (1) · Dyssomnias (1)
Aripiprazole (2) · Exercise (1) · Eye Movement Desensitization Reprocessing (1) · Fluvoxamine (1) · Observation (1) · Paliperidone Palmitate (1) · Physical Therapy Modalities (1) · Transcranial Direct Current Stimulation (1) · Transcranial Magnetic Stimulation (1) · Waiting Lists (1) · cariprazine (1) · trospium chloride (1) · xanomeline (1)
Jiangsu Hansoh Pharmaceutical Co., Ltd. (3) · Washington University School of Medicine (3) · King's College London (2) · The Hashemite University (2) · The Jerzy Kukuczka Academy of Physical Education in Katowice (2) · Alejandro Alva (1) · Ataturk University (1) · Aydin Adnan Menderes University (1) · Azienda Sanitaria Locale Napoli 3 Sud, UOCSM Torre del Greco (1) · Beth Israel Deaconess Medical Center (1) · Dicle University (1) · Humanis Saglık Anonim Sirketi (1) · Hôpital le Vinatier (1) · International University of La Rioja (1) · Johns Hopkins University (1)
United States (10) · Turkey (Türkiye) (6) · China (4) · Denmark (2) · Israel (2) · Poland (2) · Spain (2) · Egypt (1) · France (1) · India (1) · Italy (1) · Jordan (1) · United Kingdom (1)
Deanna Barch, PhD (2) · Laura Piejko, PT, PhD (2) · Nikolai Albert (2) · Abdallah Abu Khait, Ph.D.,MSN (1) · Akira Sawa, MD (1) · Alejandro Alva, MD (1) · Antigona Martinez, PhD (1) · Daniel C Javitt, MD, PhD (1) · Deanna Barch, Ph.D. (1) · Dr Caroline Lawlor (1) · Felice F. Carabellese, Medical doctor, Full Professor (1) · Fiza Singh, MD (1)
PMID 33861952, PMID 33914891, PMID 36418846, PMID 36711165, PMID 39117276, PMID 40063391, PMID 42184934, PMID 21334602, PMID 22710617, PMID 23522057, PMID 23817024, PMID 25273286, PMID 25979608, PMID 26160288, PMID 26200928, PMID 26494483, PMID 28406662, PMID 28740827, PMID 30260448, PMID 30704863, PMID 30953588, PMID 31811557, PMID 32799938, PMID 33878489, PMID 35128308, PMID 36173600, PMID 36931706, PMID 37314113, PMID 38616053, PMID 22035996, PMID 24037621, PMID 25675960, PMID 27239096, PMID 34598786, PMID 34647290, PMID 35237135, PMID 42568860
R01MH084840 (3), R01MH138939 (1)